Business
Merck Agreed to Purchase Imago BioSciences to Gain Therapies for Bone Marrow Conditions ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Merck agreed to purchase Imago BioSciences to gain therapies for bone marrow conditions that lead to overproduction of blood cells, including one drug in mid-stage trials ...'
Merck agreed to purchase Imago BioSciences to gain therapies for bone marrow conditions that lead to overproduction of blood cells, including one drug in mid-stage trials https://t.co/D1JYWN7zGG— Bloomberg (@business) November 21, 2022
(The above story first appeared on LatestLY on Nov 21, 2022 06:31 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
